View in EDS HTML Full Text PDF Full Text

Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.

Saved in:
Bibliographic Details
Title: Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
Authors: Ceuppens H; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., De Ridder K; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Ertveldt T; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Zeven K; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., De Mey W; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., Pombo Antunes AR; Precirix NV/SA, Brussels, Belgium., Navarro L; Precirix NV/SA, Brussels, Belgium., Dumauthioz N; Precirix NV/SA, Brussels, Belgium., Lahoutte T; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Debacker JM; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Devoogdt N; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Keyaerts M; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., D'Huyvetter M; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium., Goyvaerts C; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Breckpot K; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.
Source: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2540054. Date of Electronic Publication: 2025 Aug 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40747762
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune modulation following α and β<superscript>-</superscript> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ceuppens+H%22">Ceuppens H</searchLink>; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Ridder+K%22">De Ridder K</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Ertveldt+T%22">Ertveldt T</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Zeven+K%22">Zeven K</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Mey+W%22">De Mey W</searchLink>; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Pombo+Antunes+AR%22">Pombo Antunes AR</searchLink>; Precirix NV/SA, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Navarro+L%22">Navarro L</searchLink>; Precirix NV/SA, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Dumauthioz+N%22">Dumauthioz N</searchLink>; Precirix NV/SA, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Lahoutte+T%22">Lahoutte T</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Debacker+JM%22">Debacker JM</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Devoogdt+N%22">Devoogdt N</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Keyaerts+M%22">Keyaerts M</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22D'Huyvetter+M%22">D'Huyvetter M</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Goyvaerts+C%22">Goyvaerts C</searchLink>; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Breckpot+K%22">Breckpot K</searchLink>; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2540054. <i>Date of Electronic Publication: </i>2025 Aug 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40747762
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2025.2540054
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2540054
    Titles:
      – TitleFull: Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ceuppens H
      – PersonEntity:
          Name:
            NameFull: De Ridder K
      – PersonEntity:
          Name:
            NameFull: Ertveldt T
      – PersonEntity:
          Name:
            NameFull: Zeven K
      – PersonEntity:
          Name:
            NameFull: De Mey W
      – PersonEntity:
          Name:
            NameFull: Pombo Antunes AR
      – PersonEntity:
          Name:
            NameFull: Navarro L
      – PersonEntity:
          Name:
            NameFull: Dumauthioz N
      – PersonEntity:
          Name:
            NameFull: Lahoutte T
      – PersonEntity:
          Name:
            NameFull: Debacker JM
      – PersonEntity:
          Name:
            NameFull: Devoogdt N
      – PersonEntity:
          Name:
            NameFull: Keyaerts M
      – PersonEntity:
          Name:
            NameFull: D'Huyvetter M
      – PersonEntity:
          Name:
            NameFull: Goyvaerts C
      – PersonEntity:
          Name:
            NameFull: Breckpot K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1